Streetbeat News

Products Services

META

Meta and Universal Music Group have announced an expanded global multi-year agreement to enhance creative and commercial opportunities for UMG artists and songwriters across Meta platforms, including Facebook, Instagram, Messenger, Horizon, Threads, and WhatsApp.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:05 pm

MSTR

MicroStrategy shares fell by 3.10% in pre-market trading, reflecting Bitcoin's performance near $58,000. The company's strong association with Bitcoin has led to significant stock returns but also exposes it to cryptocurrency market volatility.

Portfolio Pulse from Benzinga Neuro

August 12, 2024 | 12:05 pm

EXK

Endeavour Silver shares are trading lower after the company announced a significant equipment failure at the Guanacevi mill, leading to a suspension of material processing for up to 12 weeks.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:05 pm

AEMD

Aethlon Medical has received ethics approval to conduct a clinical trial of its Hemopurifier in patients with solid tumors unresponsive to anti-PD-1 therapy. The trial will take place at Pindara Private Hospital in Queensland, Australia.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:03 pm

MASI

Masimo's W1 Medical Watch has received FDA 510(k) clearance for connectivity to the Masimo SafetyNet Telemonitoring System, enhancing its remote patient monitoring capabilities.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:03 pm

RVNC

Crown Laboratories and Revance Therapeutics have announced a merger to create a leading high-growth aesthetics and skincare company. The merger will combine flagship brands such as DAXXIFY, RHA Collection, SkinPen, PanOxyl, Blue Lizard, and StriVectin, offering global commercialization potential and enhanced product development with an experienced leadership team.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:02 pm

TNXP

Tonix Pharmaceuticals presented positive Phase 3 trial data for TNX-102 SL, showing significant improvements in fibromyalgia pain and sleep quality. The FDA has granted Fast Track designation, with an NDA submission expected in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:01 pm

LENZ

LENZ Therapeutics has submitted a New Drug Application (NDA) to the FDA for LNZ100, a treatment for presbyopia. This marks a significant milestone for the company as it seeks regulatory approval for its new drug.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:01 pm

PRZO

ParaZero shares are trading higher after the company received an order from a defense company for 50 drone safety systems intended for military operational use.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:54 am

NKLA

TSLA

Nikola CEO Steve Girsky expressed confidence in the company's hydrogen fuel cell trucks over battery electric trucks, citing better performance in certain conditions. Nikola reported strong Q2 sales and production growth, despite recalling some battery electric trucks. Tesla's Semi truck is set to start production by 2025, with CEO Elon Musk remaining skeptical about hydrogen fuel cells.

Portfolio Pulse from Anan Ashraf

August 12, 2024 | 11:54 am